HI homepage

PHOTO GALLERY: Radiology technologies at RSNA 2025

See some of the latest medical imaging technologies from around the expo floor at the 2025 Radiological Society of North America (RSNA) meeting.

 

Prenuvo MRI
Whole-body MRI provider Prenuvo loses bid to limit damages in high-profile malpractice case

Sean Clifford filed the lawsuit Sept. 24, 2024, in the New York State Supreme Court, contending a radiologist failed to spot signs of a forthcoming stroke.   

insurance insurer payment claim denial reimbursement prior authorization
Integrating prior authorization into clinical workflows cuts costs, speeds up decisions

This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology. 

IV hospital room intravenous drip solution
Ketamine a safe sedation alternative in the interventional radiology suite

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

healthcare surprise billing statement payment
Insurers fudging payment estimates for radiology services under No Surprises Act

A new analysis claims the “benchmark” qualifying payment amount insurers calculate often “dramatically” understates the actual median in-network rates they are paying for in-network care.  

breast radiologist breast cancer mammography
North American imaging experts endorse new international breast biopsy guidelines

The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.